Spruce Biosciences, Inc.Spruce Biosciences, Inc.Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.72 M‬USD
−85.92USD
‪−53.04 M‬USD
‪4.91 M‬USD
‪494.27 K‬
Beta (1Y)
0.90
Employees (FY)
21
Change (1Y)
−8 −27.59%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Meiwu Technology Company Limited


CEO
Javier Szwarcberg
Headquarters
South San Francisco
Founded
2014
ISIN
US85209E2081
FIGI
BBG00HYZ1522
Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Check out other big names from the same industry as SPRB.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Spruce Biosciences, Inc. stocks are traded under the ticker SPRB.
We've gathered analysts' opinions on Spruce Biosciences, Inc. future price: according to them, SPRB price has a max estimate of 750.00 USD and a min estimate of 750.00 USD. Watch SPRB chart and read a more detailed Spruce Biosciences, Inc. stock forecast: see what analysts think of Spruce Biosciences, Inc. and suggest that you do with its stocks.
SPRB reached its all-time high on Feb 26, 2024 with the price of 5.49 USD, and its all-time low was 0.16 USD and was reached on Apr 25, 2025. View more price dynamics on SPRB chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Spruce Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Spruce Biosciences, Inc. is going to release the next earnings report on Nov 17, 2025. Keep track of upcoming events with our Earnings Calendar.
SPRB earnings for the last quarter are −3.50 USD per share, whereas the estimation was −18.00 USD resulting in a 80.56% surprise. The estimated earnings for the next quarter are −15.56 USD per share. See more details about Spruce Biosciences, Inc. earnings.
Spruce Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SPRB net income for the last quarter is ‪−2.07 M‬ USD, while the quarter before that showed ‪−14.04 M‬ USD of net income which accounts for 85.28% change. Track more Spruce Biosciences, Inc. financial stats to get the full picture.
No, SPRB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 22, 2025, the company has 21 employees. See our rating of the largest employees — is Spruce Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Spruce Biosciences, Inc. EBITDA is ‪−50.63 M‬ USD, and current EBITDA margin is ‪−1.14 K‬%. See more stats in Spruce Biosciences, Inc. financial statements.
Like other stocks, SPRB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Spruce Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.